Nov. 16, 2026  — Trulieve Cannabis Corp. (NYSE: TRLV) (“Trulieve” or “the Company”), a leading and top-performing medical cannabis company in the U.S., today announced that the company is set to join to the Russell 2000® and 3000® Indices as part of the semi-annual Russell Indexes reconstitution, according to a preliminary list published by FTSE Russell on Friday, November 13, 2026. Final index membership is scheduled to become effective after the market close on Friday, Dec 11, 2026.

“We are thrilled to join the Russell 2000® and 3000® Indices, following uplisting to the New York Stock Exchange and domestication to the United States,” said Trulieve Chief Executive Officer Kim Rivers. “This marks another major milestone for Trulieve, building on our inclusion in the S&P Total Market, S&P Completion, and Morningstar Total Stock Market indices earlier this year. Index inclusion raises awareness of Trulieve, ultimately leading to greater liquidity and access to institutional investors.”

The Russell 2000® Index is a leading benchmark for the small-cap segment of the U.S. equity market. The index is a subset of the Russell 3000® Index and is widely used by investment managers and institutional investors for index funds and as a benchmark for active investment strategies. According to FTSE Russell, approximately $12 trillion in assets are benchmarked to or invested in products based on the U.S. Russell Indexes.